-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Clemence Aldebert1*, Emily Duan2*, Sylwia Jasinski, MD2*, Talia H Ostrow2*, Isaiah Gonzalez2*, Aristotelis Tsirigos, PhD3*, Elizabeth A. Raetz, MD4,5, Nikki Ann Evensen, PhD, BS2 and William L. Carroll, MD2,4

1Laura and Isaac Perlmutter Cancer Center, NYU Langone health, New York, NY
2Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY
3Department of Applied Bioinformatics, New York University Langone Health, New York, NY
4Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, NYU Langone Health, New York, NY
5Laura and Isaac Perlmutter Cancer Center, NYU langone Health, New York, NY

Irina Pushel, PhD1*, Midhat S. Farooqi, MD, PhD1,2*, Byunggil Yoo, MS1*, Kai Tan, PhD3,4, Kathrin M. Bernt, MD5 and Erin Guest, MD6,7

1Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO
2Department of Pathology, University of Missouri - Kansas City School of Medicine, Kansas City, MO
3Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
5Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
6Department of Pediatrics, University of Missouri - Kansas City School of Medicine, Kansas City, MO
7Children's Mercy Kansas City, Kansas City, MO

Sean I. Tracy, MD, PhD1, Hrishi Venkatesh1*, Miriam Arroyo, B.S.1*, Todd Knutson2*, Ashenafi Tilahun1*, Bartosz Grzywacz, MD3 and Michael Farrar, PhD4

1University of Minnesota, Minneapolis, MN
2Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN
3Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
4Center for Immunology, University of Minnesota, Minneapolis, MN

Trisha Tee1*, Titine Ruiter1*, Danique Wajon1*, Shuiyan Wu, MD, PhD1,2*, Ahmed Dahaoui1*, Dorette S van Ingen Schenau1*, Laurens T van der Meer, PhD1 and Frank N van Leeuwen, PhD1

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China

Jordi Ribera1*, Isabel Granada, PhD2*, Teresa González, PhD3*, Mireia Morgades4*, Olga Garcia5*, Ricardo Sanchez6,7,8*, Esperanza Such, PhD9*, Susana Barrena, PhD10*, Juana Ciudad, PhD11*, Beatriz Soriano12*, Rocio Benito, PhD13*, Gayane Avetisyan14*, Eva Lumbreras3*, Cristina Miguel-García, BSc15*, Sandra Santos-Mínguez3*, Lurdes Zamora, PhD1,16*, Mar Mallo, Ph.D.17*, Celia González-Gil18*, Eulàlia Genescà, PhD18*, Thaysa Lopes1*, Jesús María Hernández-Rivas, MD, PhD19,20,21,22,23, Alberto Orfao, MD, PhD11,24,25 and Josep-Maria Ribera, MD, PhD4

1Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Spain
2ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
3Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
4Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
5Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain
6Hematology, Hospital Universitario 12 de Octurbe, Madrid, Spain
7Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical research unit, CIBERONC, Madrid, Spain
8Altum sequencing Co., Madrid, Spain
9Hematology Department., Hospital Universitario y Politécnico La Fe, Valencia, Spain
10Cytometry Service (NUCLEUS), Department of Medicine and IBSAL, Cancer Research Center (IBMCC, University of Salamanca-CSIC), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain
11IBSAL, IBMCC, Centro de Investigación del Cáncer, CIBERONC, Universidad de Salamanca-CSIC, Hospital Universitario, Salamanca, Spain
12Servicio General de Citometría/Universidad de Salamanca (Nucleus), Centro de Investigación del Cáncer/IBMCC (CSIC), Salamanca, Salamanca, Spain
13Servicio de Hematología, Hospital Universitario de Salamanca (HUSAL/IBSAL), and IBMCC (USAL-CSIC), Salamanca, Spain
14Servicio de Hematología. Hospital La Fe, Valencia, Spain
15Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain
16Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
17Josep Carreras Leukemia Research Institute (IJC), ICO-Hospital GermansTrias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
18Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
19HARMONY Alliance Chair, Salamanca, Spain
20Department of Hematology, University Hospital of Salamanca, IBSAL, Salamanca, Spain
21Department of Hematology, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Cancer Research Center, Salamanca, Spain
22Cancer Research Center (IBMCC) CSIC, University of Salamanca, Salamanca, Spain
23IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, Salamanca, Spain
24Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain
25Cancer Research Centre (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca and IBSAL, Salamanca, Spain

Heiko Mueller, PhD1*, Wencke Walter, PhD1*, Stephan Hutter, PhD1*, Niroshan Nadarajah1*, Frank Dicker, PhD1, Manja Meggendorfer, PhD1, Qingsong Gao2*, Ilaria Iacobucci, PhD3, Charles G. Mullighan, MBBS, MD2, Wolfgang Kern, MD1, Torsten Haferlach, MD1 and Claudia Haferlach, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2St. Jude Children's Research Hospital, Memphis, TN
3Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN

Deborah Cardinali, PhD student1*, Irene Della Starza, PhD1,2*, Vittorio Bellomarino, Bs1*, Marco Beldinanzi, PhD student1*, Mariangela Di Trani, Bs1*, Felicetto Ferrara, MD3*, Monica Bocchia, MD4*, Prassede Salutari, MD5*, Monia Lunghi, MD, PhD6*, Erika Borlenghi, M.D.7*, Matteo Piccini8*, Catello Califano, MD9*, Alfonso Piciocchi, MS2*, Maria Stefania De Propris, PhD1*, Robin Foà, Full professor1* and Sabina Chiaretti, MD, PhD1

1Hematology, Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy
2GIMEMA Foundation, Rome, Italy
3+390817472241, Napoli, Italy
4Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy, Siena, Italy
5Dipartimento Oncologia Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy
6Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
7Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
8SOD Ematologia, SOD Ematologia, Università Di Firenze, AOU Careggi, Firenze, Italy, Firenze, Italy
9Onco-Ematologia Ospedale Pagani, Salerno, Italy

Fieke W Hoff, MD, PhD1, Lourdes Sriraja2*, Yihua Qiu3*, Gaye Jenkins, BS4*, Andrew Ligeralde5*, David T. Teachey, MD6, Brent L. Wood, MD PhD7, Meenakshi Devidas, PhD, MBA8, Mignon L. Loh, MD9, Todd A. Alonzo, PhD10*, Amina A Qutub, PhD11*, Evangelia Petsalaki12*, Steven M. Kornblau, MD3 and Terzah M. Horton, MD, PhD4

1UT Southwestern Medical Center, Dallas, TX
22European Molecular Biology Laboratory, Hinxton, United Kingdom
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Baylor College of Medicine, Houston, TX
5University of California, Berkeley, CA
6Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Rutledge, PA
7Children's Hospital Los Angeles, Los Angeles, CA
8Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN
9Department of Pediatrics, Benioff Children's Hospital, University of California San Francisco, San Francisco, CA
10Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
11The University of Texas at San Antonio, San Antonio
12European Molecular Biology Laboratory, Hinxton, United Kingdom

Ruimin Hong1*, Linghui Zhou, MD2*, Ye Meng2*, Mingming Zhang2*, Houli Zhao, MD2*, Jiazhen Cui2,3,4*, Simao Huang2,3,4,5*, Yongxian Hu6* and He Huang2,5,7,8

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Province, AL, China
2Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China
4Institute of Hematology, Zhejiang University, Hangzhou, China
5Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
6Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, China
7Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
8Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou 311121, China, Hangzhou, China

Daniel Leongamornlert, PhD1*, Jesús Gutiérrez-Abril2*, SooWah Lee, MSc3*, Emilio Barretta4*, Thomas Creasey4*, Krisztina Zuborne Alapi, MSc3*, Max F. Levine, MS2*, Juan E Arango-Ossa2*, Juan S Medina-Martinez2*, Amy A. Kirkwood, MSc5*, Laura Clifton-Hadley, BSc, PhD5*, Pip Patrick, PhD, MSc, MA5*, David Jones1*, Adam P Butler1*, Christine J. Harrison, PhD, FRCPath4, Peter J. Campbell1*, Bela Patel Wrench, MD6*, Anthony V. Moorman4, Adele K. Fielding, MBBS, PhD3 and Elli Papaemmanuil, PhD2

1Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, United Kingdom
2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
3UCL Cancer Institute, London, United Kingdom
4Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
5Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
6Department of Haemato-Oncology, Queen Mary University of London, London, United Kingdom

Alexandra Niedermayer1*, Stefanie Enzenmüller1*, Felix Seyfried1*, Daniel Tews1*, Pamela Fischer-Posovszky1*, Ulrich Rupp2*, Paul Walther2*, Klaus-Michael Debatin1 and Lüder Hinrich Meyer1*

1Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
2Central Facility for Electron Microscopy, Ulm University, Ulm, Germany

Matthew M Klairmont, MD1, William L. Carroll, MD2, Iannis Aifantis, PhD3 and Christopher Y. Park, MD, PhD1

1Pathology, New York University School of Medicine, New York, NY
2NYU School of Medicine, New York, NY
3Department of Pathology, New York University School of Medicine, New York, NY

Xiaojie Liang1*, Bingqing Tang1*, Cai Zihong1*, Zicong Huang1*, Baiwei Luo2*, Bingyu Lin2*, Yunong Yang2*, Qifa Liu, MD1 and Hongsheng Zhou1*

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2The First Clinical Medical College, Guangdong Medical University, Zhanjiang, China

Carol Fries Simpson, MD1, Janice M Spence2*, Cameron Baker, MS3*, Aayush Poudel4*, John P Spence, PhD5*, Philip J Rock6*, Hongyue Wang, PhD7*, Diana G Adlowitz, PhD2*, Helene R McMurray, PhD8*, Andrew McDavid, PhD9* and Richard Burack, MD, PhD6

1Department of Pediatrics, Pediatric Hematology & Oncology, University of Rochester, Rochester, NY
2Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY
3Biostatistics, Genomics Research Center, University of Rochester, Rochester, NY
4School of Medicine and Dentistry, University of Rochester, Rochester, NY
5NGS Tech, Albany, NY
6Department of Pathology and Laboratory Medicine/Hematopathology, University of Rochester Medical Center, Rochester, NY
7Biostatistics, University of Rochester, Rochester, NY
8Department of Pathology and Laboratory Medicine, Department of Biomedical Genetics, University of Rochester, Rochester, NY
9Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY

Diego Alberto Barcenas-Lopez, MSc1,2, Juan Carlos Nuñez-Enriquez, PhD3*, Laura Lucila Gomez-Romero, PhD4*, Hugo Antonio Tovar-Romero, PhD4*, Elva Jimenez-Hernandez, PhD5*, Aurora Medina-Sanson, MD6*, Jose Gabriel Peñaloza-Gonzalez, MD7*, Luz Victoria Flores Villegas, MD, Hematology8*, Minerva Mata-Rocha, PhD9*, Haydee Rosas-Vargas, PhD9*, Alfredo Hidalgo-Miranda, PhD2*, Juan Manuel Mejia-Arangure, PhD2 and Silvia Jimenez-Morales, PhD2*

1Biological Sciences Graduate Studies Program, National Autonomous University of Mexico, Coyoacan, Mexico City, Mexico
2Cancer Genomics Laboratory, National Institute of Genomic Medicine, Tlalpan, DF, Mexico
3Clinical Epidemiology Division. National Medical Center “Siglo XXI”, Mexican Institute of Social Security, Cuauhtemoc, DF, Mexico
4Computational Genomics Department, National Institute of Genomic Medicine, Tlalpan, DF, Mexico
5Pediatric Hematology Department. National Medical Center “La Raza”, Mexican Institute of Social Security, Azcapotzalco, DF, Mexico
6Hematological Oncology Department, Children’s Hospital of Mexico “Federico Gomez”, Cuauhtemoc, DF, Mexico
7Pediatric Oncology Department, Juarez Hospital of Mexico, Gustavo A Madero, DF, Mexico
8Pediatric Hematology, National Medical Center "20 de Noviembre" ISSSTE, Mexico City, MEX
9Human Genetics Research Department. National Medical Center “Siglo XXI”, Mexican Institute of Social Security, Cuauhtemoc, DF, Mexico

Chiara Palmi, PhD1*, Silvia Bresolin, PhD2*, Stefanie V. Junk3*, Grazia Fazio, PhD4*, Daniela Silvestri, Dr5*, Marketa Zaliova6, Athanasios Oikonomou4*, Katerina Scharov7*, Martin Stanulla, MD, MSc8*, Anja Moericke9*, Martin Zimmermann, PhD10*, Martin Schrappe, MD11, Barbara Buldini12*, Claudia Saitta, PhD4*, Marta Galbiati13*, Michela Bardini, PhD1*, Sanil Bhatia, PhD14*, Arndt Borkhardt, MD7, Luca Lo Nigro, PhD, MD15, Valentino Conter, MD16*, Maria Grazia Valsecchi, PhD5,17*, Andrea Biondi, MD4, Geertruij Te Kronnie18*, Gunnar Cario19* and Giovanni Cazzaniga, PhD20,21*

1Tettamanti Research Center, Pediatrics, Department of Medicine, University of Milano-Bicocca, Monza, Italy
2SDB Department, Pediatric Hemato-Oncology, University of Padova, Padova, Italy
3Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
4Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
5Centro Operativo di Ricerca Statistica, Fondazione Tettamanti, Monza, Italy
6CLIP - Childhood Leukemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
7Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
8Pediatric Hematology and Oncology, Hannover Medical School (MHH), Hanover, Germany
9Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
10Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany
11University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
12Women's and children's health department, onco-hematology lab and clinic, University-Hospital of Padova, Padova, Italy
13Centro Ricerca Tettamanti, University of Milano Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
14Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
15Center of Pediatric Hematology and Oncology, Azienda Policlinico-San Marco, Catania, Italy
16Department of Pediatrics, Pediatric Hematology-Oncology Unit, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
17Statistics, University of Milan Bicocca, Monza, Italy
18Woman and Child Health Department, OncoHematology Lab, University of Padua, Padua, Italy
19Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany, Kiel, Germany
20Medical Genetics, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
21Tettamanti Research Center, Pediatrics, University of Milano-Bicocca / Fondazione Tettamanti, Monza, Italy

Amir Enshaei, PhD1*, Javier Martinez Martínez Elicegui2*, Esther Anguiano3*, Jude Gibson4*, Mirella Ampatzidou5*, Michael Doubek, MD, PhD6, Adele K. Fielding, MBBS, PhD7, Edoardo La Sala, MSc8*, Elizabeth Middleton9*, Anita W. Rijneveld, MD, PhD10*, Amin T. Turki, MD11, Ajay Vora, MD12, Martin Zimmermann, PhD13* and Anthony V. Moorman14

1Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom
2Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
3Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
4Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
5Department of Pediatric Hematology-Oncology, "Aghia Sophia” Children’s Hospital, Athens, Greece
6Department of Internal Medicine - Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
7Cancer Institute, University College London, London, United Kingdom
8Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
9Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom
10Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands
11Department of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, Germany
12Department of Haematology, The Children's Hospital, London, United Kingdom
13Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
14Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, United Kingdom

*signifies non-member of ASH